GREAT CHI HLDGS (00021): Zhong Weiheng Appointed as Independent Non-Executive Director
GREAT CHI HLDGS (00021) announces that Mr. Liang Kun has resigned as an independent non-executive director with effect from October 2, 2026, due to personal reasons. Following his resignation, Mr. Liang Kun also ceases to be a member of the Company's audit committee, the Company's remuneration committee, and the Company's nomination committee.
GREAT CHI HLDGS (00021) announced that Mr. Liang Kun has resigned as an independent non-executive director with effect from October 2, 2026, due to personal reasons. Following his resignation, Mr. Liang Kun also ceased to be a member of the Company's audit committee, the Company's remuneration committee, and the Company's nomination committee.
Ms. Zhong Weiheng has been appointed as an independent non-executive director and a member of the audit committee, remuneration committee, and nomination committee, with effect from October 2, 2026.
Related Articles
Futu Trustee Limited increased its shareholding in GAUSH MEDITECH (02407) by 13,000 shares at approximately HK$4.61 per share.
JIUFANG DIGITAL (08238) proposes to issue convertible bonds with an aggregate principal amount of HK$13.92 million
JPMorgan reduces its holdings in GENSCRIPT BIO (01548) by approximately 33.751 million shares at approximately HK$32.74 per share.
Futu Trustee Limited increased its shareholding in GAUSH MEDITECH (02407) by 13,000 shares at approximately HK$4.61 per share.
JIUFANG DIGITAL (08238) proposes to issue convertible bonds with an aggregate principal amount of HK$13.92 million
JPMorgan reduces its holdings in GENSCRIPT BIO (01548) by approximately 33.751 million shares at approximately HK$32.74 per share.
RECOMMEND
